Tg Therapeutics Inc (TGTX)
$61.18 +5.34% Close Oct 30, 2026 Live
Tg Therapeutics stock today
Tg Therapeutics closed at $61.18 on October 30, 2026, up 5.34% on the day. Over the past year it returned +79.8% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $9.37 billion.
$30.00$40.00$50.00$60.00
NovJan 2026MarMayJulSep
| Period | TGTX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +9.7% | -0.9% |
| 3 months | +14.3% | +2.1% |
| Year to date | +105.2% | +11.7% |
| 1 year | +79.8% | +12.4% |
| 3 years | +727.9% | +88.5% |
| 5 years | +96.0% | +76.0% |
Key statistics
- Market value
- $9.37B
- P/E (trailing)
- 22.3
- Forward P/E
- 33.5
- Price / sales
- 11.7
- 52-week range
- $26.94 to $61.18
- Next report
- Nov 2, 2026 (estimated)
About Tg Therapeutics
Develops oncology and immunology therapeutic treatments.
Sector: Health Care
More on Tg Therapeutics
- Financials: revenue, earnings and segmentsRevenue +87% in the year to Dec 2025
- Valuation: P/E history and peersP/E 22.3, median 189.8 at its last 3 year ends
- Returns: what $1,000 became$1,000 ten years ago is $10,809 today
No forecast, no recommendation. This page describes Tg Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.